Zacks Rating on Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : Zacks Investment Research ranks Varian Medical Systems (VAR) as 3, which is a Hold recommendation. 3 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 2.06, which indicates as a Buy.

Varian Medical Systems (VAR) : 5 Wall Street analysts covering Varian Medical Systems (VAR) believe that the average level the stock could reach for the short term is $92.8. The maximum price target given is $102 and the minimum target for short term is around $86, hence the standard deviation is calculated at $6.98.


Shares of Varian Medical Systems, Inc. rose by 1.53% in the last five trading days and 9.74% for the last 4 weeks. Varian Medical Systems, Inc. is up 14.03% in the last 3-month period. Year-to-Date the stock performance stands at 17.66%. Varian Medical Systems (NYSE:VAR): On Tuesdays trading session , Opening price of the stock was $95.55 with an intraday high of $95.6. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $95.07. However, the stock managed to close at $95.07, a loss of 0.16% for the day. On the previous day, the stock had closed at $95.22. The total traded volume of the day was 364,348 shares.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.